Vicarious Surgical shareholders approve dissolution

Date: 2026-07-22
Type: ARTICLE
Deck: The surgical-robotics company is winding down five years after a $1.1B SPAC deal, without reaching commercial sale.
URL: https://korthos.xyz/research/vicarious-surgical-shareholders-approve-dissolution

Vicarious Surgical shareholders have approved the dissolution of the surgical robotics company, five years after it entered public markets at a $1.1 billion valuation.
The 2021 SPAC deal was expected to leave Vicarious with more than $425 million in cash.
It projected $355 million in revenue by 2025 and was backed by investors including Bill Gates, Khosla Ventures, BD and Innovation Endeavors.
Its system placed two robotic arms and a camera through a single small abdominal incision, initially targeting ventral hernia repair.
Despite FDA Breakthrough Device designation, the robot never received authorization or reached commercial sale. Its submission timeline repeatedly slipped as Vicarious redesigned the system, cut staff and depleted its capital.
By March, it held $3.7 million in cash and short-term investments against $9 million in liabilities.
Shareholders approved the dissolution on July 21. Vicarious then transferred substantially all its assets for liquidation, with creditors taking priority.
The company says shareholders are unlikely to receive any distribution.
---
Have a robotics update Korthos should review? Send news, deployments, product releases, funding rounds, research, or media to tips@korthos.xyz or reach out on X at @agkorthos.